Literature DB >> 15223302

Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.

Olaf Jahn1, Hossein Tezval, Lars van Werven, Klaus Eckart, Joachim Spiess.   

Abstract

Corticotropin-releasing factor (CRF) and the CRF-like peptide urocortin I (UcnI) exert their activity through two different CRF receptors, CRF1 and CRF2. Recently, UcnII and UcnIII have been discovered as potential endogenous agonists selective for CRF2 known to be involved in brain functions such as learning and anxiety, as well as in cardiovascular functions. A structure-affinity relationship study using chimeric peptides was designed to characterize mouse UcnII (mUcnII) and mUcnIII further and to investigate the structural basis of their receptor subtype selectivity. In the framework of this study, mUcnII (IC50 = 4.4 nM) but not mUcnIII was identified as high-affinity ligand for the rat CRF binding protein. Such affinity had previously not been observed for the human version of this protein. On the basis of secondary structure predictions, it was hypothesized that the amino acid motifs Pro-Ile-Gly of mUcnII and Pro-Thr-Asn of mUcnIII decrease alpha-helicity and thereby impair binding to CRF1. In support of this hypothesis, binding affinity to CRF1 of the chimeric peptides [Pro11Ile12Gly13]h/rCRF, [Pro11Thr12Asn13]h/rCRF, and the corresponding rUcnI analogs was found to be decreased by three orders of magnitude, whereas binding affinity to CRF2 was much less affected. The dramatic decrease in binding affinity to CRF1 correlated with a decrease in alpha-helicity as indicated by the data of circular dichroism spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223302     DOI: 10.1016/j.neuropharm.2004.03.018

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

1.  CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons.

Authors:  Arthur C Riegel; John T Williams
Journal:  Neuron       Date:  2008-02-28       Impact factor: 17.173

Review 2.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.

Authors:  Eva M Fekete; Koki Inoue; Yu Zhao; Jean E Rivier; Wylie W Vale; Attila Szücs; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2006-10-04       Impact factor: 7.853

Review 4.  The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?

Authors:  Carolina L Haass-Koffler
Journal:  Alcohol       Date:  2017-10-13       Impact factor: 2.405

5.  Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice.

Authors:  Lixin Wang; Andreas Stengel; Miriam Goebel; Vicente Martinez; Guillaume Gourcerol; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2010-10-20       Impact factor: 3.750

Review 6.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

Review 7.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

8.  Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe.

Authors:  M S Clark; R A McDevitt; B J Hoplight; J F Neumaier
Journal:  Neuroscience       Date:  2007-04-30       Impact factor: 3.590

9.  Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2.

Authors:  Pietro Cottone; Valentina Sabino; Tim R Nagy; Donald V Coscina; Eric P Zorrilla
Journal:  J Physiol       Date:  2007-07-12       Impact factor: 5.182

10.  Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens.

Authors:  Jenny Campos-Salinas; Marta Caro; Antonio Cavazzuti; Irene Forte-Lago; Stephen M Beverley; Francisco O'Valle; Elena Gonzalez-Rey
Journal:  J Immunol       Date:  2013-11-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.